Biotechnology plays a pivotal role in advancing tissue engineering, a field focused on creating functional biological tissues for medical applications. Tissue Engineering aims to repair or replace damaged or diseased tissues using a combination of cells, biomaterials, and biotechnological approaches. Biotechnology facilitates the isolation, expansion, and manipulation of cells used in tissue engineering, including stem cells and other specialized cell types. These cells can be genetically modified or induced to differentiate into specific lineages essential for tissue regeneration. The use of biocompatible biomaterials is a key aspect of tissue engineering, and biotechnological methods are employed to design scaffolds that mimic the natural extracellular matrix. These scaffolds provide a supportive environment for cell attachment, proliferation, and tissue formation. Biotechnology contributes to the development of advanced bioreactors that simulate physiological conditions, enhancing the maturation of engineered tissues. Bioreactors can apply mechanical forces, perfuse nutrients, and maintain optimal oxygen levels to promote tissue development. In tissue engineering, biotechnological tools are harnessed for the controlled release of growth factors, cytokines, and other bioactive molecules, influencing cellular behavior and promoting tissue regeneration. Techniques such as gene editing and gene delivery enable precise manipulation of cellular functions. Challenges in tissue engineering include achieving vascularization within engineered tissues and ensuring proper integration with the host. Ongoing research in biotechnology continues to drive innovation in tissue engineering, offering promising solutions for regenerative medicine and personalized healthcare.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy